Comparison of Prolonged Bivalirudin Infusion Versus Intraprocedural in Preventing Myocardial Damage After Percutaneous Coronary Intervention in Patients With Angina Pectoris

American Journal of Cardiology

Volumn 104, Issue 8, 2009, Pages 1063-1068

  Cortese, Bernardo ^a   Picchi, Andrea ^a   Micheli, Andrea ^a   Ebert, Alberto Genovesi ^b   Parri, Francesca ^a   Severi, Silva ^a   Limbruno, Ugo ^a  

^a MISERICORDIA HOSPITAL   (Italy)

^b Livorno Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; CREATINE KINASE MB; HIRULOG;

ANGINA PECTORIS; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; HEART INFARCTION; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; STABLE ANGINA PECTORIS; UNSTABLE ANGINA PECTORIS;

AGED; ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTICOAGULANTS; ANTITHROMBINS; DELAYED-ACTION PREPARATIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HIRUDINS; HUMANS; INCIDENCE; INFUSIONS, INTRAVENOUS; ITALY; MALE; MYOCARDIAL INFARCTION; PEPTIDE FRAGMENTS; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 70349480920     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.06.005     Document Type: Article

References (25)

1. Lincoff A.M., Bittl J.A., Harrington R.A., Feit F., Kleiman N.S., Jackman J.D., Sarembock I.J., Cohen D.J., Spriggs D., Ebrahimi R., Keren G., Carr J., Cohen E.A., Betriu A., Desmet W., Kereiakes D.J., Rutsch W., Wilcox R.G., de Feyter P.J., Vahanian A., and Topol E.J. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. JAMA 289 (2003) 853-863
2. Stone G.W., White H.D., Ohman E.M., Bertrand M.E., Lincoff A.M., McLaurin B.T., Cox D.A., Pocock S.J., Ware J.H., Feit F., Colombo A., Manoukian S.V., Lansky A.J., Mehran R., and Moses J.W. Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial. Lancet 369 (2007) 907-919
3. Stone G.W., McLaurin B.T., Cox D.A., Bertrand M.E., Lincoff A.M., Moses J.W., White H.D., Pocock S.J., Ware J.H., Feit F., Colombo A., Aylward P.E., Cequier A.R., Darius H., Desmet W., Ebrahimi R., Hamon M., Rasmussen L.H., Rupprecht H.J., Hoekstra J., Mehran R., and Ohman E.M. Bivalirudin for patients with acute coronary syndromes. N Engl J Med 355 (2006) 2203-2216
4. Stone G.W., Witzenbichler B., Guagliumi G., Peruga J.Z., Brodie B.R., Dudek D., Kornowski R., Hartmann F., Gersh B.J., Pocock S.J., Dangas G., Wong S.C., Kirtane A.J., Parise H., and Mehran R. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med 358 (2008) 2218-2230
5. Bittl J.A. Accounting for ACUITY. N Engl J Med 355 (2006) 2249-2250
6. Morrow D.A. Antithrombotic therapy to support primary PCI. N Engl J Med 358 (2008) 2280-2282
7. Waksman R. ACUITY-PCI: one drug does not fit all. Lancet 369 (2007) 881-882
8. Ellis S.G., Vandormael M.G., Cowley M.J., DiSciascio G., Deligonul U., Topol E.J., Bulle T.M., and Multivessel Angioplasty Prognosis Study Group. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Circulation 82 (1990) 1193-1202
9. Mehran R., Brodie B., Cox D.A., Grines C.L., Rutherford B., Bhatt D.L., Dangas G., Feit F., Ohman E.M., Parise H., Fahy M., Lansky A.J., and Stone G.W. The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial: study design and rationale. Am Heart J 156 (2008) 44-56
10. Jeremias A., Baim D.S., Ho K.K., Chauhan M., Carrozza Jr. J.P., Cohen D.J., Popma J.J., Kuntz R.E., and Cutlip D.E. Differential mortality risk of postprocedural creatine kinase-MB elevation following successful versus unsuccessful stent procedures. J Am Coll Cardiol 44 (2004) 1210-1214
11. Briguori C., Colombo A., Airoldi F., Violante A., Focaccio A., Balestrieri P., Paolo Elia P., Golia B., Lepore S., Riviezzo G., Scarpato P., Librera M., Bonizzoni E., and Ricciardelli B. Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction. Eur Heart J 25 (2004) 1822-1828
12. Cutlip D.E., and Kuntz R.E. Cardiac enzyme elevation after successful percutaneous coronary intervention is not an independent predictor of adverse outcome. Circulation 112 (2005) 916-922
13. Montalescot G., Sideris G., Meuleman C., Bal-dit-Sollier C., Lellouche N., Steg P.G., Slama M., Milleron O., Collet J.P., Henry P., Beygui F., and Drouet L. A randomized comparison of high clopidogrel loading doses in patients with non-ST-segment elevation acute coronary syndromes: the ALBION (Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis) trial. J Am Coll Cardiol 48 (2006) 931-938
14. Gibson C.M., Morrow D.A., Murphy S.A., Palabrica T.M., Jennings L.K., Stone P.H., Lui H.H., Bulle T., Lakkis N., Kovach R., Cohen D.J., Fish P., McCabe C.H., and Braunwald E. A randomized trial to evaluate the relative protection against post-percutaneous coronary intervention microvascular dysfunction, ischemia, and inflammation among antiplatelet and antithrombotic agents: the PROTECT-TIMI-30 trial. J Am Coll Cardiol 47 (2006) 2364-2373
15. Kastrati A., Neumann F.J., Mehilli J., Byrne R.A., Iijima R., Buttner H.J., Khattab A.A., Schulz S., Blankenship J.C., Pache J., Minners J., Seyfarth M., Graf I., Skelding K.A., Dirschinger J., Richardt G., Berger P.B., and Schomig A. Bivalirudin versus unfractionated heparin during percutaneous coronary intervention. N Engl J Med 359 (2008) 688-696
16. Ricciardi M.J., Wu E., Davidson C.J., Choi K.M., Klocke F.J., Bonow R.O., Judd R.M., and Kim R.J. Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation. Circulation 103 (2001) 2780-2783
17. Ioannidis J.P., Karvouni E., and Katritsis D.G. Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention. J Am Coll Cardiol 42 (2003) 1406-1411
18. Varani E., Balducelli M., Vecchi G., Gatti C., Lucchi G.R., and Maresta A. Occurrence of non-Q wave myocardial infarction following percutaneous coronary intervention in the stent era: systematic monitoring of the three markers of myocardial necrosis. J Interv Cardiol 18 (2005) 243-248
19. Matthews M.A., Kunselman S.J., Gascho J.A., and Gilchrist I.C. Differential release of cardiac enzymes after percutaneous coronary intervention. Catheter Cardiovasc Interv 65 (2005) 19-24
20. Schofer J., Lampe F., Mathey D.G., Muller-Hansen S., and Voigt K.D. Increase in creatine kinase and its MM isoforms after successful and uncomplicated coronary angioplasty. Z Kardiol 81 (1992) 326-330
21. Weitz J.I., and Bates S.M. Acute coronary syndromes: a focus on thrombin. J Invasive Cardiol 14 suppl B (2002) 2B-7B
22. Schneider D.J., Keating F., and Sobel B.E. Greater inhibitory effects of bivalirudin compared with unfractionated heparin plus eptifibatide on thrombin-induced platelet activation. Coron Artery Dis 17 (2006) 471-476
23. Prati F., Pawlowski T., Gil R., Labellarte A., Gziut A., Caradonna E., Manzoli A., Pappalardo A., Burzotta F., and Boccanelli A. Stenting of culprit lesions in unstable angina leads to a marked reduction in plaque burden: a major role of plaque embolization?. A serial intravascular ultrasound study. Circulation 107 (2003) 2320-2325
24. Uetani T., Amano T., Ando H., Yokoi K., Arai K., Kato M., Marui N., Nanki M., Matsubara T., Ishii H., Izawa H., and Murohara T. The correlation between lipid volume in the target lesion, measured by integrated backscatter intravascular ultrasound, and post-procedural myocardial infarction in patients with elective stent implantation. Eur Heart J 29 (2008) 1714-1720
25. Fuchs J., and Cannon C.P. Hirulog in the treatment of unstable angina. Results of the Thrombin Inhibition in Myocardial Ischemia (TIMI) 7 trial. Circulation 92 (1995) 727-733